AU - Asuke, Sunday
AU - Bimba, John
AU - Ngutor, Swem
AU - Ejiga, Eunice
AU - Miracle, Shanabo
AU - Anamayi, Dorcas
TI - Prevalence of tuberculosis-HIV co-infection and factors associated with treatment outcome among the tuberculosis patients in HIV treatment facility in a teaching hospital in Jos, North Central Nigeria
PT - ORIG
DP - 2020 Sep 1
TA - Port Harcourt Medical Journal
PG - 119-124
VI - 14
IP - 3
4099- https://www.phmj.org/article.asp?issn=0795-3038;year=2020;volume=14;issue=3;spage=119;epage=124;aulast=Asuke;type=0
4100- https://www.phmj.org/article.asp?issn=0795-3038;year=2020;volume=14;issue=3;spage=119;epage=124;aulast=Asuke
AB -
Background: Globally, tuberculosis (TB) remains a disease of grave public health concern. It ranks above HIV/AIDS as the leading cause of death from a single infectious agent, and as one of the 10 most common causes of mortality. This study assessed the prevalence of TB-HIV co-infection and factors associated with treatment outcome among the TB patients in an HIV treatment facility in a Teaching hospital in Jos, North central Nigeria.
Methods: A 10-year retrospective, descriptive cross-sectional review was conducted and data was extracted through the review of TB registers. Data were analysed using SPSS version 20 and bivariate analyses was conducted at P < 0.05.
Results: The prevalence of TB-HIV co-infection was 9.25%, with the mean age of the study participants being 41.8 ± 11.6 years. Of all the participants, 87.5% had successful treatment outcome, while 12.5% had unsuccessful treatment outcome. In the bivariate analysis, place of residence was the only socio-demographic factor significantly associated with treatment outcome (<0.001).
Conclusion: The TB-HIV co-infection prevalence rate was about 10% of the total HIV population with a high TB treatment success rate. With the exception of place of residence, no other factor had statistically significant relationship with the treatment outcome.